PALB2 and non-small cell lung carcinoma: Notably, the genes of the HRR pathway were also included in this study, but there are only two patients that harbored PALB2 (member of the HRR pathway) gene mutation, so the impact of PALB2 mutation on the prognosis of NSCLC patients was not analyzed.